{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,9,26]],"date-time":"2025-09-26T00:18:57Z","timestamp":1758845937141,"version":"3.44.0"},"reference-count":35,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,9,25]],"date-time":"2025-09-25T00:00:00Z","timestamp":1758758400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2025,9,25]],"date-time":"2025-09-25T00:00:00Z","timestamp":1758758400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sci Rep"],"DOI":"10.1038\/s41598-025-16787-8","type":"journal-article","created":{"date-parts":[[2025,9,25]],"date-time":"2025-09-25T13:27:23Z","timestamp":1758806843000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Association of serum trace elements with non-invasive fibrosis scores in metabolic dysfunction-associated steatotic liver disease"],"prefix":"10.1038","volume":"15","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-7825-2759","authenticated-orcid":false,"given":"Erfan","family":"Banisefid","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0009-0006-3448-8130","authenticated-orcid":false,"given":"Sahand Karkon","family":"Zonouzi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5344-4885","authenticated-orcid":false,"given":"Sina","family":"Hamzehzadeh","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6522-1048","authenticated-orcid":false,"given":"Zeinab","family":"Nikniaz","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0009-0004-3560-2308","authenticated-orcid":false,"given":"Seyedehyasmin","family":"Moghaddamziabari","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9764-7713","authenticated-orcid":false,"given":"Leila","family":"Alizadeh","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2025,9,25]]},"reference":[{"issue":"3","key":"16787_CR1","doi-asserted-by":"publisher","first-page":"197","DOI":"10.7570\/jomes23052","volume":"32","author":"WK Chan","year":"2023","unstructured":"Chan, W. K. et al. Metabolic dysfunction-associated steatotic liver disease (MASLD): A state-of-the-art review. J. Obes. Metab. Syndr. 32 (3), 197\u2013213 (2023).","journal-title":"J. Obes. Metab. Syndr."},{"issue":"6","key":"16787_CR2","first-page":"e86963","volume":"17","author":"MMA Hashim","year":"2025","unstructured":"Hashim, M. M. A. et al. Pathological evolution and internal medicine management of nonalcoholic fatty liver disease (NAFLD) in the era of metabolic dysfunction-associated steatotic liver disease (MASLD). Cureus 17 (6), e86963 (2025).","journal-title":"Cureus"},{"issue":"10","key":"16787_CR3","doi-asserted-by":"publisher","first-page":"e0240195","DOI":"10.1371\/journal.pone.0240195","volume":"15","author":"MC Kim","year":"2020","unstructured":"Kim, M. C. et al. Serum zinc level and hepatic fibrosis in patients with nonalcoholic fatty liver disease. PLoS One. 15 (10), e0240195 (2020).","journal-title":"PLoS One"},{"issue":"4","key":"16787_CR4","doi-asserted-by":"publisher","first-page":"846","DOI":"10.1002\/hep.21496","volume":"45","author":"P Angulo","year":"2007","unstructured":"Angulo, P. et al. The NAFLD fibrosis score: a noninvasive system that identifies liver fibrosis in patients with NAFLD. Hepatology 45 (4), 846\u2013854 (2007).","journal-title":"Hepatology"},{"issue":"2","key":"16787_CR5","doi-asserted-by":"publisher","first-page":"389","DOI":"10.1053\/j.gastro.2015.04.043","volume":"149","author":"P Angulo","year":"2015","unstructured":"Angulo, P. et al. Liver fibrosis, but no other histologic features, is associated with Long-term outcomes of patients with nonalcoholic fatty liver disease. Gastroenterology 149 (2), 389\u201397e10 (2015).","journal-title":"Gastroenterology"},{"issue":"Suppl","key":"16787_CR6","doi-asserted-by":"publisher","first-page":"S32","DOI":"10.3350\/cmh.2024.0431","volume":"31","author":"ZM Younossi","year":"2025","unstructured":"Younossi, Z. M., Kalligeros, M. & Henry, L. Epidemiology of metabolic dysfunction-associated steatotic liver disease. Clin. Mol. Hepatol. 31 (Suppl), S32\u2013s50 (2025).","journal-title":"Clin. Mol. Hepatol."},{"issue":"1","key":"16787_CR7","doi-asserted-by":"publisher","first-page":"73","DOI":"10.1002\/hep.28431","volume":"64","author":"ZM Younossi","year":"2016","unstructured":"Younossi, Z. M. et al. Global epidemiology of nonalcoholic fatty liver disease-Meta-analytic assessment of prevalence, incidence, and outcomes. Hepatology. 64 (1), 73\u201384 (2016).","journal-title":"Hepatology"},{"issue":"3","key":"16787_CR8","first-page":"149","volume":"7","author":"I Moghaddasifar","year":"2016","unstructured":"Moghaddasifar, I. et al. Prevalence of non-alcoholic fatty liver disease and its related factors in Iran. Int. J. Organ. Transpl. Med. 7 (3), 149\u2013160 (2016).","journal-title":"Int. J. Organ. Transpl. Med."},{"issue":"11","key":"16787_CR9","doi-asserted-by":"publisher","first-page":"686","DOI":"10.1038\/nrgastro.2013.171","volume":"10","author":"R Loomba","year":"2013","unstructured":"Loomba, R. & Sanyal, A. J. The global NAFLD epidemic. Nat. Rev. Gastroenterol. Hepatol. 10 (11), 686\u2013690 (2013).","journal-title":"Nat. Rev. Gastroenterol. Hepatol."},{"issue":"1","key":"16787_CR10","doi-asserted-by":"publisher","first-page":"19","DOI":"10.1007\/s12576-017-0571-7","volume":"68","author":"J Olechnowicz","year":"2018","unstructured":"Olechnowicz, J., Tinkov, A., Skalny, A. & Suliburska, J. Zinc status is associated with inflammation, oxidative stress, lipid, and glucose metabolism. J. Physiol. Sci. 68 (1), 19\u201331 (2018).","journal-title":"J. Physiol. Sci."},{"issue":"4","key":"16787_CR11","doi-asserted-by":"publisher","first-page":"563","DOI":"10.1079\/PNS2004386","volume":"63","author":"P Sharp","year":"2004","unstructured":"Sharp, P. The molecular basis of copper and iron interactions. Proc. Nutr. Soc. 63 (4), 563\u2013569 (2004).","journal-title":"Proc. Nutr. Soc."},{"issue":"27","key":"16787_CR12","doi-asserted-by":"publisher","first-page":"20507","DOI":"10.1074\/jbc.M109.090027","volume":"285","author":"N Maio","year":"2010","unstructured":"Maio, N. et al. Role of external loops of human ceruloplasmin in copper loading by ATP7B and Ccc2p. J. Biol. Chem. 285 (27), 20507\u201320513 (2010).","journal-title":"J. Biol. Chem."},{"issue":"9","key":"16787_CR13","doi-asserted-by":"publisher","first-page":"1978","DOI":"10.1038\/ajg.2010.170","volume":"105","author":"E Aigner","year":"2010","unstructured":"Aigner, E. et al. A role for low hepatic copper concentrations in nonalcoholic fatty liver disease. Am. J. Gastroenterol. 105 (9), 1978\u20131985 (2010).","journal-title":"Am. J. Gastroenterol."},{"issue":"10","key":"16787_CR14","doi-asserted-by":"publisher","first-page":"996","DOI":"10.1016\/j.jnutbio.2015.04.009","volume":"26","author":"S Tallino","year":"2015","unstructured":"Tallino, S. et al. Nutrigenomics analysis reveals that copper deficiency and dietary sucrose up-regulate inflammation, fibrosis and lipogenic pathways in a mature rat model of nonalcoholic fatty liver disease. J. Nutr. Biochem. 26 (10), 996\u20131006 (2015).","journal-title":"J. Nutr. Biochem."},{"issue":"8","key":"16787_CR15","doi-asserted-by":"publisher","first-page":"959","DOI":"10.1177\/153537020322800812","volume":"228","author":"JR Prohaska","year":"2003","unstructured":"Prohaska, J. R., Geissler, J., Brokate, B. & Broderius, M. Copper, zinc-superoxide dismutase protein but not mRNA is lower in copper-deficient mice and mice lacking the copper chaperone for superoxide dismutase. Exp. Biol. Med. (Maywood). 228 (8), 959\u2013966 (2003).","journal-title":"Exp. Biol. Med. (Maywood)"},{"key":"16787_CR16","doi-asserted-by":"publisher","first-page":"112295","DOI":"10.1016\/j.ecoenv.2021.112295","volume":"218","author":"C Chen","year":"2021","unstructured":"Chen, C. et al. Copper exposure association with prevalence of non-alcoholic fatty liver disease and insulin resistance among US adults (NHANES 2011\u20132014). Ecotoxicol. Environ. Saf. 218, 112295 (2021).","journal-title":"Ecotoxicol. Environ. Saf."},{"key":"16787_CR17","doi-asserted-by":"crossref","unstructured":"Antonucci, L., Porcu, C., Iannucci, G., Balsano, C. & Barbaro, B. Non-Alcoholic fatty liver disease and nutritional implications: special focus on copper. Nutrients. 9(10). (2017).","DOI":"10.3390\/nu9101137"},{"key":"16787_CR18","doi-asserted-by":"publisher","first-page":"103220","DOI":"10.1016\/j.etap.2019.103220","volume":"71","author":"T Ameh","year":"2019","unstructured":"Ameh, T. & Sayes, C. M. The potential exposure and hazards of copper nanoparticles: A review. Environ. Toxicol. Pharmacol. 71, 103220 (2019).","journal-title":"Environ. Toxicol. Pharmacol."},{"issue":"1","key":"16787_CR19","doi-asserted-by":"publisher","first-page":"17","DOI":"10.30699\/ijp.14.1.17","volume":"14","author":"F Kosari","year":"2019","unstructured":"Kosari, F., Jamali, R., Ramim, T. & Mosavi Jahan Abad, E. The correlation between serum zinc level and liver histology in non-alcoholic steatohepatitis. Iran. J. Pathol. 14 (1), 17\u201325 (2019).","journal-title":"Iran. J. Pathol."},{"issue":"5","key":"16787_CR20","doi-asserted-by":"publisher","first-page":"1259","DOI":"10.1016\/j.numecd.2022.01.035","volume":"32","author":"SD Chen","year":"2022","unstructured":"Chen, S. D. et al. J-shaped relationship between serum zinc levels and the severity of hepatic necro-inflammation in patients with MAFLD. Nutr. Metab. Cardiovasc. Dis. 32 (5), 1259\u20131265 (2022).","journal-title":"Nutr. Metab. Cardiovasc. Dis."},{"issue":"2","key":"16787_CR21","doi-asserted-by":"publisher","first-page":"288","DOI":"10.1007\/s12011-017-1059-2","volume":"181","author":"SN Mousavi","year":"2018","unstructured":"Mousavi, S. N. et al. Zinc and selenium co-supplementation reduces some lipid peroxidation and angiogenesis markers in a rat model of NAFLD-Fed high fat diet. Biol. Trace Elem. Res. 181 (2), 288\u2013295 (2018).","journal-title":"Biol. Trace Elem. Res."},{"key":"16787_CR22","doi-asserted-by":"publisher","first-page":"108905","DOI":"10.1016\/j.fsi.2023.108905","volume":"139","author":"J Cui","year":"2023","unstructured":"Cui, J., Xu, T., Lv, H. & Guo, M. Y. Zinc deficiency causes oxidative stress, endoplasmic reticulum stress, apoptosis and inflammation in hepatocytes in grass carp. Fish. Shellf. Immunol. 139, 108905 (2023).","journal-title":"Fish. Shellfish Immunol."},{"issue":"6","key":"16787_CR23","doi-asserted-by":"publisher","first-page":"748","DOI":"10.1097\/MEG.0000000000001587","volume":"32","author":"T Ito","year":"2020","unstructured":"Ito, T. et al. Correlation of serum zinc levels with pathological and laboratory findings in patients with nonalcoholic fatty liver disease. Eur. J. Gastroenterol. Hepatol. 32 (6), 748\u2013753 (2020).","journal-title":"Eur. J. Gastroenterol. Hepatol."},{"issue":"10","key":"16787_CR24","doi-asserted-by":"publisher","first-page":"1104","DOI":"10.1016\/j.cgh.2009.05.033","volume":"7","author":"AG Shah","year":"2009","unstructured":"Shah, A. G. et al. Comparison of noninvasive markers of fibrosis in patients with nonalcoholic fatty liver disease. Clin. Gastroenterol. Hepatol. 7 (10), 1104\u20131112 (2009).","journal-title":"Clin. Gastroenterol. Hepatol."},{"issue":"8","key":"16787_CR25","doi-asserted-by":"publisher","first-page":"1973","DOI":"10.1111\/j.1572-0241.2008.01954.x","volume":"103","author":"MA Loko","year":"2008","unstructured":"Loko, M. A. et al. Validation and comparison of simple noninvasive indexes for predicting liver fibrosis in HIV-HCV-coinfected patients: ANRS CO3 Aquitaine cohort. Am. J. Gastroenterol. 103 (8), 1973\u20131980 (2008).","journal-title":"Am. J. Gastroenterol."},{"issue":"12","key":"16787_CR26","doi-asserted-by":"publisher","first-page":"Cr735","DOI":"10.12659\/MSM.883601","volume":"18","author":"H Cicho\u017c-Lach","year":"2012","unstructured":"Cicho\u017c-Lach, H. et al. The BARD score and the NAFLD fibrosis score in the assessment of advanced liver fibrosis in nonalcoholic fatty liver disease. Med. Sci. Monit. 18 (12), Cr735\u2013Cr740 (2012).","journal-title":"Med. Sci. Monit."},{"issue":"2","key":"16787_CR27","doi-asserted-by":"publisher","first-page":"147","DOI":"10.3164\/jcbn.14-33","volume":"55","author":"K Iwata","year":"2014","unstructured":"Iwata, K. et al. Serum zinc value in patients with hepatitis virus-related chronic liver disease: association with the histological degree of liver fibrosis and with the severity of varices in compensated cirrhosis. J. Clin. Biochem. Nutr. 55 (2), 147\u2013152 (2014).","journal-title":"J. Clin. Biochem. Nutr."},{"issue":"11","key":"16787_CR28","doi-asserted-by":"publisher","first-page":"1967","DOI":"10.1007\/s10620-005-9051-7","volume":"51","author":"M Moriyama","year":"2006","unstructured":"Moriyama, M. et al. Clinical significance of evaluation of serum zinc concentrations in C-viral chronic liver disease. Dig. Dis. Sci. 51 (11), 1967\u20131977 (2006).","journal-title":"Dig. Dis. Sci."},{"key":"16787_CR29","doi-asserted-by":"crossref","unstructured":"Semeya, A. A., Elgamal, R. & Othman, A. A. A. Correlation of serum zinc levels with hepatic encephalopathy severity in patients with decompensated liver cirrhosis: A prospective observational study from Egypt. Biol. Trace Elem. Res. (2025).","DOI":"10.1007\/s12011-025-04544-x"},{"issue":"9","key":"16787_CR30","doi-asserted-by":"publisher","first-page":"694","DOI":"10.1046\/j.1440-1681.2000.03322.x","volume":"27","author":"M Cabr\u00e9","year":"2000","unstructured":"Cabr\u00e9, M., Camps, J., Patern\u00e1in, J. L., Ferr\u00e9, N. & Joven, J. Time-course of changes in hepatic lipid peroxidation and glutathione metabolism in rats with carbon tetrachloride-induced cirrhosis. Clin. Exp. Pharmacol. Physiol. 27 (9), 694\u2013699 (2000).","journal-title":"Clin. Exp. Pharmacol. Physiol."},{"key":"16787_CR31","doi-asserted-by":"crossref","unstructured":"Himoto, T. & Masaki, T. Associations between zinc deficiency and metabolic abnormalities in patients with chronic liver disease. Nutrients. 10(1). (2018).","DOI":"10.3390\/nu10010088"},{"issue":"2","key":"16787_CR32","doi-asserted-by":"publisher","first-page":"458","DOI":"10.1002\/hep.21262","volume":"44","author":"V Nobili","year":"2006","unstructured":"Nobili, V. et al. NAFLD in children: a prospective clinical-pathological study and effect of lifestyle advice. Hepatology. 44 (2), 458\u2013465 (2006).","journal-title":"Hepatology"},{"key":"16787_CR33","doi-asserted-by":"publisher","first-page":"1095916","DOI":"10.3389\/fpubh.2023.1095916","volume":"11","author":"Y Chen","year":"2023","unstructured":"Chen, Y., Wu, C., Li, G., Wang, W. & Tang, S. Comparison of copper concentration between non-alcoholic fatty liver disease patients and normal individuals: A meta-analysis. Front. Public. Health. 11, 1095916 (2023).","journal-title":"Front. Public. Health"},{"issue":"3","key":"16787_CR34","doi-asserted-by":"publisher","first-page":"506","DOI":"10.1016\/j.jhep.2021.03.014","volume":"75","author":"E Corradini","year":"2021","unstructured":"Corradini, E. et al. Ceruloplasmin gene variants are associated with hyperferritinemia and increased liver iron in patients with NAFLD. J. Hepatol. 75 (3), 506\u2013513 (2021).","journal-title":"J. Hepatol."},{"key":"16787_CR35","doi-asserted-by":"publisher","first-page":"S128","DOI":"10.14309\/00000434-201410002-00427","volume":"109","author":"D Issa","year":"2014","unstructured":"Issa, D., Lopez, R., Feldstein, A., Alsabbagh, M. & Alkhouri, N. Serum ceruloplasmin, ferritin, and their ratio are significantly associated with nonalcoholic steatohepatitis in patients with NAFLD: 427. Am. J. Gastroenterol. 109, S128 (2014).","journal-title":"Am. J. Gastroenterol."}],"container-title":["Scientific Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-16787-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-16787-8","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-16787-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,9,25]],"date-time":"2025-09-25T13:27:26Z","timestamp":1758806846000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-16787-8"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,9,25]]},"references-count":35,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["16787"],"URL":"https:\/\/doi.org\/10.1038\/s41598-025-16787-8","relation":{},"ISSN":["2045-2322"],"issn-type":[{"value":"2045-2322","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,9,25]]},"assertion":[{"value":"24 May 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"19 August 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"25 September 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}},{"value":"The study process was reviewed and approved by the ethics committee of Tabriz University of Medical Sciences, according to the Declaration of Helsinki (ethics code: IR.TBZMED.REC.1401.292). Before collecting data, informed consent was obtained from all patients. All methods were carried out according to relevant guidelines and regulations.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval and consent to participate"}}],"article-number":"32837"}}